Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi)

This study aims to see if adding the drug Evinacumab to standard treatment can better control dangerous plaque buildup in the arteries of people with a rare, severe form of genetic high cholesterol (HoFH). Researchers will compare two groups of about 52 patients: one receiving Ev…